Terms: = Lymphoma AND FANCE, 2178, ENSG00000112039, FAE
13 results:
1. Clinical Trials Portfolio and Regulatory History of Idelalisib in Indolent Non-Hodgkin lymphoma: A Systematic Review and Meta-analysis.
Banerjee T; Kim MS; Haslam A; Prasad V
JAMA Intern Med; 2023 May; 183(5):435-441. PubMed ID: 36939665
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological characteristics and genetic variations of uterine tumours resembling ovarian sex cord tumours.
Ye S; Wu J; Yao L; He J
J Clin Pathol; 2022 Nov; 75(11):776-781. PubMed ID: 34348985
[TBL] [Abstract] [Full Text] [Related]
3. Nonmyeloablative TLI-ATG conditioning for allogeneic transplantation: mature follow-up from a large single-center cohort.
Spinner MA; Kennedy VE; Tamaresis JS; Lavori PW; Arai S; Johnston LJ; Meyer EH; Miklos DB; Muffly LS; Negrin RS; Rezvani AR; Shizuru JA; Weng WK; Hoppe RT; Strober S; Lowsky R
Blood Adv; 2019 Aug; 3(16):2454-2464. PubMed ID: 31427277
[TBL] [Abstract] [Full Text] [Related]
4. Enhanced DNA repair and genomic stability identify a novel HIV-related diffuse large B-cell lymphoma signature.
Maguire A; Chen X; Wisner L; Malasi S; Ramsower C; Kendrick S; Barrett MT; Glinsmann-Gibson B; McGrath M; Rimsza LM
Int J Cancer; 2019 Dec; 145(11):3078-3088. PubMed ID: 31044434
[TBL] [Abstract] [Full Text] [Related]
5. Five-year follow-up of lenalidomide plus rituximab as initial treatment of mantle cell lymphoma.
Ruan J; Martin P; Christos P; Cerchietti L; Tam W; Shah B; Schuster SJ; Rodriguez A; Hyman D; Calvo-Vidal MN; Smith SM; Svoboda J; Furman RR; Coleman M; Leonard JP
Blood; 2018 Nov; 132(19):2016-2025. PubMed ID: 30181173
[TBL] [Abstract] [Full Text] [Related]
6. Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Giebel S; Labopin M; Socié G; Beelen D; Browne P; Volin L; Kyrcz-Krzemien S; Yakoub-Agha I; Aljurf M; Wu D; Michallet M; Arnold R; Mohty M; Nagler A
Haematologica; 2017 Jan; 102(1):139-149. PubMed ID: 27686376
[TBL] [Abstract] [Full Text] [Related]
7. Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies.
Kantarjian HM; Stein AS; Bargou RC; Grande Garcia C; Larson RA; Stelljes M; Gökbuget N; Zugmaier G; Benjamin JE; Zhang A; Jia C; Topp MS
Cancer; 2016 Jul; 122(14):2178-85. PubMed ID: 27143254
[TBL] [Abstract] [Full Text] [Related]
8. Occupational exposure to endocrine disruptors and lymphoma risk in a multi-centric European study.
Costas L; Infante-Rivard C; Zock JP; Van Tongeren M; Boffetta P; Cusson A; Robles C; Casabonne D; Benavente Y; Becker N; Brennan P; Foretova L; Maynadié M; Staines A; Nieters A; Cocco P; de Sanjosé S
Br J Cancer; 2015 Mar; 112(7):1251-6. PubMed ID: 25742473
[TBL] [Abstract] [Full Text] [Related]
9. Characteristics of Sweet Syndrome in patients with acute myeloid leukemia.
Kazmi SM; Pemmaraju N; Patel KP; Cohen PR; Daver N; Tran KM; Ravandi F; Duvic M; Garcia-Manero G; Pierce S; Nazha A; Borthakur G; Kantarjian H; Cortes J
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):358-363. PubMed ID: 25630528
[TBL] [Abstract] [Full Text] [Related]
10. The molecular biology of Fanconi anemia.
Tamary H; Bar-Yam R; Zemach M; Dgany O; Shalmon L; Yaniv I
Isr Med Assoc J; 2002 Oct; 4(10):819-23. PubMed ID: 12389351
[TBL] [Abstract] [Full Text] [Related]
11. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.
Caro JJ; Salas M; Ward A; Goss G
Cancer; 2001 Jun; 91(12):2214-21. PubMed ID: 11413508
[TBL] [Abstract] [Full Text] [Related]
12. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
Schrappe M; Reiter A; Ludwig WD; Harbott J; Zimmermann M; Hiddemann W; Niemeyer C; Henze G; Feldges A; Zintl F; Kornhuber B; Ritter J; Welte K; Gadner H; Riehm H
Blood; 2000 Jun; 95(11):3310-22. PubMed ID: 10828010
[TBL] [Abstract] [Full Text] [Related]
13. Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease.
Trümper L; Jung W; Dahl G; Diehl V; Gause A; Pfreundschuh M
Ann Oncol; 1994; 5 Suppl 1():93-6. PubMed ID: 8172827
[TBL] [Abstract] [Full Text] [Related]
